GlassScriptPhysician profile
Boyd Nelson Bills
NPI 1205221173
$12,248.43
in general payments reported to CMS, 2019-2025
28 companies · $2,270 in 2025
The $2,270 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,798 · 2020: $83.71 · 2021: $1,835 · 2022: $1,251 · 2023: $499 · 2024: $3,513 · 2025: $2,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,367 · Travel and Lodging: $2,315 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.99 |
| Travel and Lodging | $2,315.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,943.31 | 2019-2025 | Infinity, Prophecy, Allowrap |
| Wright Medical Technology, INC. | $2,076.00 | 2019 | |
| Medinc of Texas | $1,865.01 | 2019-2022 | |
| Kerecis Limited | $1,641.13 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mission Medical Distribution, LLC | $898.67 | 2024-2025 | |
| Depuy Synthes Sales INC. | $558.12 | 2019-2024 | Motoband, Va-Lcp |
| Arthrex, INC. | $462.45 | 2025 | |
| Smith+Nephew, INC. | $316.97 | 2019-2024 | Pico, Collagenase Santyl |
| Nevro Corp. | $314.64 | 2022 | |
| Triad Life Sciences INC. | $185.62 | 2022 | |
| Acera Surgical, INC. | $146.31 | 2022-2023 | Restrata Wound Matrix |
| Carbofix Orthopedics INC | $105.49 | 2025 | |
| Trilliant Surgical LLC. | $103.39 | 2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Nvision Biomedical Technologies, INC. | $97.31 | 2022 | |
| Integra Lifesciences Corporation | $78.43 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $77.95 | 2021-2023 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $75.76 | 2024-2025 | |
| Nabriva Therapeutics, Plc | $56.94 | 2022 | |
| Bioventus LLC | $45.88 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $42.75 | 2022 | |
| Abbvie INC. | $33.26 | 2023 | Dalvance |
| Medline Industries LP | $26.96 | 2022-2023 | |
| Orthofix Medical, INC. | $24.08 | 2019 | |
| Convatec INC. | $17.77 | 2023 | |
| Axogen | $14.22 | 2020 | |
| Paratek Pharmaceuticals, INC. | $14.21 | 2022 | |
| Medtronic, INC. | $13.72 | 2022 | |
| Tactile Systems Technology INC | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boyd Bills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.